These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats. Sun L; Ke Y; Zhu CY; Tang N; Tian DK; Gao YH; Zheng JP; Bian K Chin Med J (Engl); 2008 Nov; 121(22):2305-11. PubMed ID: 19080338 [TBL] [Abstract][Full Text] [Related]
9. PPARs as therapeutic targets in cardiovascular disease. van Bilsen M; van Nieuwenhoven FA Expert Opin Ther Targets; 2010 Oct; 14(10):1029-45. PubMed ID: 20854178 [TBL] [Abstract][Full Text] [Related]
10. Alpha-alkyl substituted pirinixic acid derivatives as potent dual agonists of the peroxisome proliferator activated receptor alpha and gamma. Rau O; Syha Y; Zettl H; Kock M; Bock A; Schubert-Zsilavecz M Arch Pharm (Weinheim); 2008 Mar; 341(3):191-5. PubMed ID: 18275039 [TBL] [Abstract][Full Text] [Related]
11. Unlike PPARgamma, PPARalpha or PPARbeta/delta activation does not promote human monocyte differentiation toward alternative macrophages. Bouhlel MA; Brozek J; Derudas B; Zawadzki C; Jude B; Staels B; Chinetti-Gbaguidi G Biochem Biophys Res Commun; 2009 Aug; 386(3):459-62. PubMed ID: 19527689 [TBL] [Abstract][Full Text] [Related]
12. Therapeutical effects of PPAR agonists assessed by biomarker modulation. Chinetti-Gbaguidi G; Fruchart JC; Staels B Biomarkers; 2005 Nov; 10 Suppl 1():S30-6. PubMed ID: 16298909 [TBL] [Abstract][Full Text] [Related]
13. PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome. Fiévet C; Fruchart JC; Staels B Curr Opin Pharmacol; 2006 Dec; 6(6):606-14. PubMed ID: 16973418 [TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma (PPARgamma): Is the genomic activity the only answer? Luconi M; Cantini G; Serio M Steroids; 2010; 75(8-9):585-94. PubMed ID: 19900469 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation, and molecular modeling investigation of new chiral fibrates with PPARalpha and PPARgamma agonist activity. Pinelli A; Godio C; Laghezza A; Mitro N; Fracchiolla G; Tortorella V; Lavecchia A; Novellino E; Fruchart JC; Staels B; Crestani M; Loiodice F J Med Chem; 2005 Aug; 48(17):5509-19. PubMed ID: 16107150 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages. Souissi IJ; Billiet L; Cuaz-Pérolin C; Slimane MN; Rouis M Exp Cell Res; 2008 Nov; 314(18):3405-14. PubMed ID: 18823978 [TBL] [Abstract][Full Text] [Related]
17. In vitro screening of 200 pesticides for agonistic activity via mouse peroxisome proliferator-activated receptor (PPAR)alpha and PPARgamma and quantitative analysis of in vivo induction pathway. Takeuchi S; Matsuda T; Kobayashi S; Takahashi T; Kojima H Toxicol Appl Pharmacol; 2006 Dec; 217(3):235-44. PubMed ID: 17084873 [TBL] [Abstract][Full Text] [Related]
18. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation? Ahmed W; Ziouzenkova O; Brown J; Devchand P; Francis S; Kadakia M; Kanda T; Orasanu G; Sharlach M; Zandbergen F; Plutzky J J Intern Med; 2007 Aug; 262(2):184-98. PubMed ID: 17645586 [TBL] [Abstract][Full Text] [Related]
19. The pathophysiological function of peroxisome proliferator-activated receptor-gamma in lung-related diseases. Huang TH; Razmovski-Naumovski V; Kota BP; Lin DS; Roufogalis BD Respir Res; 2005 Sep; 6(1):102. PubMed ID: 16153299 [TBL] [Abstract][Full Text] [Related]